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Abstract
 
The Raf kinases are key signal transducers activated by mitogens or oncogenes. The best stud-
ied Raf isoform, Raf-1, was identified as an inhibitor of apoptosis by conventional and condi-
tional gene ablation in mice. 
 
c-raf-1
 
 
 
/
 
  
 
embryos are growth retarded and anemic, and die at
midgestation with anomalies in the placenta and fetal liver. Here, we show that Raf-1–defi-
cient primary erythroblasts cannot be expanded in culture due to their accelerated differentia-
tion into mature erythrocytes. In addition, Raf-1 expression is down-regulated in differentiating
wild-type cells, whereas overexpression of activated Raf-1 delays differentiation. As recently
described for human erythroid precursors, we find that caspase activation is necessary for the
differentiation of murine fetal liver erythroblasts. Differentiation-associated caspase activation is
accelerated in erythroid progenitors lacking Raf-1 and delayed by overexpression of the acti-
vated kinase. These results reveal an essential function of Raf-1 in erythropoiesis and demon-
strate that the ability of Raf-1 to restrict caspase activation is biologically relevant in a context
distinct from apoptosis.
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Introduction
 
Hematopoiesis is a complex process regulated by multiple
growth factors supporting the renewal, differentiation, and
survival of hematopoietic progenitors at different stages of
maturation. Pluripotent, multipotent, and committed pre-
cursors can undergo a number of “renewal divisions” (1).
During terminal differentiation, committed progenitors
obey a fixed program that directs both the residual number
of cell divisions and the specific timing of differentiation (2,
 
3). The correct balance between renewal and terminal
differentiation is essential for homeostasis of the hemato-
poietic system, maintaining adequate numbers of precursors
as well as mature cells, and is lost under pathological condi-
tions such as leukemia and anemia.
Apoptosis is a finely regulated process equally essential
for tissue development and homeostasis. During apoptosis,
the cell is dismantled from within by cysteine/aspartic acid
proteases (caspases) that cleave proteins involved in the
maintenance of cell shape, the integrity of the nucleus, as
well as of DNA itself (4, 5). Cleavage of these so-called
death substrates causes dramatic alterations in the shape of
the cells, some of which are reminiscent of the changes
seen during the differentiation of erythroblasts to mature
erythrocytes. Indeed, caspase activation has recently been
shown to be required for the differentiation of human
erythroblasts in culture (6).
The Raf-1 kinase has been implicated in the transduc-
tion of signals directing cell proliferation, activation, and
survival. However, conventional (7, 8) and conditional (9)
ablation of Raf-1 have revealed that the essential role of
this kinase is to prevent apoptosis rather than promote pro-
liferation. Specifically, Raf-1 seems to act by preventing
caspase activation (9). Raf-1–deficient embryos are anemic,
exhibit various grades of growth retardation, and die at
E12.5. The most prominent defects observed are placental
insufficiency and liver apoptosis. Surprisingly in view of the
anemia observed, apoptosis is restricted to the hepatoblast
compartment and does not seem to affect the erythroid
progenitors (7). Here, we address the cause of the anemic
phenotype of the Raf-1–deficient embryos. We demon-
strate that Raf-1 is degraded during erythroid maturation of
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primary mouse erythroblasts cultivated in physiologically
relevant cytokines (10) and that this kinase delays erythro-
blast differentiation by restraining the caspase activation as-
sociated with it. Thus, the anemic phenotype of Raf-1–
deficient embryos is likely due to premature erythroblast
differentiation at the expense of renewal, which depletes
the fetal liver of erythroid precursors. Our results indicate a
novel role for Raf-1 in erythropoiesis and demonstrate that
its essential function as a regulator of caspase activity is not
restricted to the control of apoptosis.
 
Materials and Methods
 
Cell Isolation, Culture, Differentiation, and Infection.
 
Primary
fetal liver cells were isolated from E11.5 or E12.0 mouse embryos
from heterozygous Raf-1 intercrosses. Bone marrow cells were
isolated from 
 
Mx-Cre;c-raf-1
 
flox/flox 
 
and 
 
c-raf-1
 
flox/flox
 
 mice after the
induction of Cre expression by poly inosinic/cytidylic acid (poly
I/C)
 
* 
 
treatment in vivo (400 
 
 
 
g intraperitoneally, every other
day, three injections total). Cells were collected 1 wk after the last
injection and the conversion of the 
 
flox
 
 to the 
 
  
 
allele was exam-
ined by PCR analysis as previously described (9). Fetal liver– and
bone marrow–derived cells and immortal mouse erythroblasts
(I/11, p53-deficient; references 10 and 11) were expanded and
maintained in serum-free erythroid medium (StemPro34™
 
 
 
plus
nutrient supplement; Life Technologies) supplemented with 2
units/ml human recombinant erythropoietin (Epo; Janssen-
Cilag), 100 ng/ml murine recombinant stem cell factor (R&D
Systems), and 10
 
 
 
6 
 
M dexamethasone (Sigma-Aldrich). 40 ng/ml
insulin-like growth factor 1 (Promega) was present in all media
described (10). Cultures were maintained at densities between 2
and 4 
 
  
 
10
 
6 
 
cells/ml and analyzed daily for cell numbers and cell
size distribution in an electronic cell counter (CASY-1; Schärfe-
System) to determine proliferation kinetics. Cumulative cell
numbers were calculated as previously described (10).
For the determination of erythroid CFUs (CFUe), fetal livers
were isolated at day E11.5 and resuspended in IMDM. 10
 
5 
 
cells
were seeded in duplicate in Methocult M3234
 
®
 
 (StemCell Tech-
nologies Inc.) in the presence of 0.3 U/ml Epo. Colonies were
counted by independent investigators after 2 and 3 d in culture.
For the experiments presented in Fig. 1 B through Fig. 4, fetal
liver or bone marrow cells were cultured for 6 d in proliferation
medium to enrich for erythroid progenitors. Immediately before
the experiment, the cells were density purified by Ficoll centrifu-
gation in 1.078 g/cm
 
3 
 
lymphocyte separation medium (Eurobio)
to remove dead and differentiated cells and obtain homogenous
populations of proliferating erythroid progenitors (12). Cells
were washed twice in PBS and reseeded at 2–3 
 
  
 
10
 
6 
 
cells/ml in
S-13 differentiation medium containing 12% FCS (Life Technol-
ogies) and supplemented with 10 units/ml Epo, insulin (4 
 
 
 
10
 
 
 
4
 
 IE 
 
  
 
10 ng/ml, Actrapid
 
® 
 
HM; Novo Nordisk), 3 
 
 
 
10
 
 
 
6 
 
M of the dexamethasone antagonist ZK112.993 (10), and 1
mg/ml iron-saturated human transferrin (Sigma-Aldrich). Differ-
entiating erythroblasts were maintained at densities between 2
and 4 
 
  
 
10
 
6 
 
cells/ml.
In selected experiments, the cells were preincubated for 1 h
with the indicated concentrations of the broad range caspase in-
hibitors Z-VAD-FMK (R&D Systems) or Caspase Inhibitor III
(Boc-D-FMK; Calbiochem-Novabiochem). Fresh inhibitors were
supplied with each medium change throughout differentiation.
I/11 erythroblasts were infected with a bicistronic retroviral
vector in which the expression of mutant forms of Raf-1 coupled
to enhanced green fluorescent protein (EGFP) via an internal ri-
bosome entry site sequence is driven by the murine stem cell vi-
rus long-terminal repeats (13). 8 d after infection, I/11 cells were
sorted on a FACSCalibur
 
® 
 
(Becton Dickinson) for EGFP expres-
sion and single cells were expanded in 96-well plates.
 
Cell Morphology, Histological Staining, FACS
 
® 
 
Analysis, and De-
termination of Hemoglobin Content.
 
Erythroblasts at various stages
of differentiation were cytocentrifuged onto glass slides and
stained with histological dyes and neutral benzidine for hemoglo-
bin (14). Nucleated and enucleated erythrocytes (brown- or or-
ange-stained small cells), partially mature or immature cells (larger
cells with gray or blue cytoplasm), and apoptotic/dead cells (frag-
mented/condensed nuclei, disintegrated cells) were counted after
visual inspection in the microscope as previously described (14),
evaluating 
 
 
 
500 cells per sample on multiple, randomly selected
fields. Bone marrow–derived cells cultured for 1 wk in erythroid
medium were stained with antibodies against c-kit–APC,
Ter119-PE, B220-APC, and Mac-1–FITC (all from BD Bio-
sciences) before FACS
 
® 
 
analysis. Hemoglobin content was ana-
lyzed by removing 50 
 
 
 
l aliquots from the cultures and photo-
metric determination was performed as previously described (10).
Values obtained from triplicate determinations were averaged and
normalized to cell number and cell volume. The highest value
measured in a given experiment was taken as 100.
 
Western Blot Analysis.
 
Erythroblasts were harvested after the
determination of cell numbers, washed with ice cold PBS, and
resuspended in 2 
 
  
 
SDS loading or lysis buffer (10 mM Tris-
HCl, pH 7.0, 50 mM sodium chloride, 30 mM sodium pyro-
phosphate, 1% Triton X-100). Insoluble material was removed
by centrifugation (14,000 rpm for 5 min). Because hemoglobin,
present in different amounts in the cells at various stages, inter-
feres with any standard method of protein determination, samples
were normalized with respect to both cell number and size and
subjected to PAGE followed by electrophoretic transfer to nylon
membranes. After blocking in TTBS (10 mM Tris-HCl, pH 8.0,
150 mM sodium chloride, 0.1% Tween 20) with 5% milk pow-
der or 2% BSA (fraction V; Sigma-Aldrich), the membranes were
probed with the appropriate primary antibodies (rabbit polyclonal
antiserum against a COOH-terminal peptide of v-raf [SP63,
CTLTTSPRLPVF], hsp90, caspase-1, caspase-3, caspase-9, and
Lamin B; Santa Cruz Biotechnology, Inc.) in 1–2% BSA in
TTBS before incubation with peroxidase-conjugated secondary
antibodies and detection by enhanced chemiluminescence (Pierce
Chemical Co.).
 
Results and Discussion
 
We have previously demonstrated that Raf-1–deficient
embryos are anemic and have hypocellular livers showing
pronounced apoptosis of the hepatoblast compartment.
Hepatoblast failure and the resulting lack of a proper mi-
croenvironment could be responsible for the impaired
hematopoiesis and the anemic phenotype. Indeed, Raf-1–
deficient fetal livers contained much less erythroid progen-
itors than WT livers as assessed in CFUe assays (Fig. 1 A).
To determine whether this was due to a defect in the fetal
liver environment or to a cell-autonomous defect of the
erythroid progenitors, we investigated the ability of Raf-
 
*
 
Abbreviations used in this paper:
 
 CFUe, erythroid CFU(s); EGFP, en-
hanced green fluorescent protein; Epo, erythropoietin; Poly I/C, poly
inosinic/cytidylic acid. 
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1–deficient erythroblasts to proliferate and differentiate in
vitro. Purified erythroblasts from E11.5 livers were culti-
vated in erythroid medium to favor proliferation but not
differentiation of erythroblasts (10). Under these condi-
tions, WT cells proliferated exponentially (eightfold total
cell number increase from day 3 to 6), whereas 
 
c-raf-1
 
 
 
/
 
 
 
cells barely doubled (Fig. 1 B). This is in line with the pre-
vious observation that antisense Raf-1 oligonucleotides re-
duce Epo and insulin-like growth factor–induced prolifer-
ation of human erythroid progenitors (15). Analysis of
cytospin preparations after 6 d in culture showed that WT
cultures contained mainly large, undifferentiated erythroid
progenitors. In contrast, the Raf-1–deficient cultures were
far more heterogeneous and contained immature cells, dif-
ferentiating blasts, and mature hemoglobinized cells (Fig. 1
C). This heterogeneity and the presence of mature cells in
the Raf-1–deficient cultures could be confirmed by cell
size profile analysis. The WT cultures consisted mainly of
large, blast-size cells (
 
 
 
10 
 
 
 
m Ø) and the 
 
c-raf-1
 
 
 
/
 
  
 
cul-
tures contained a high proportion of smaller cells, includ-
ing erythrocytes (
 
 
 
5 
 
 
 
m Ø, Fig. 1 D). Thus, Raf-1–defi-
cient fetal liver cells fail to accumulate in culture,
apparently due to accelerated differentiation at the expense
of renewal.
To further investigate the impact of the lack of Raf-1
on erythroid differentiation, density-purified erythroblasts
from fetal liver cultures (refer to Materials and Methods)
were induced to terminally differentiate by exposure to
Epo plus insulin. Neither WT nor 
 
c-raf-1
 
 
 
/
 
  
 
cells under-
went a significant degree of cell death during differentiation
(2–7% dead cells/time point), and in both cultures differen-
tiation was essentially complete after 48 h, although a larger
residual proportion of partially mature cells was observed in
the WT cultures (Fig. 2 A). At 24 h, however, 
 
c-raf-1
 
 
 
/
 
 
 
cultures showed a dramatic reduction of the number of
erythroblasts (from 82 to 27%) compensated by a similarly
dramatic increase in the numbers of nucleated (13–47%)
and enucleated (3–22%) erythrocytes, as assessed by analysis
of cytospins and cell size profiles (Fig. 2, A and B). By
comparison, WT cultures after 24 h still contained 62%
erythroblasts and only 
 
 
 
1.4% enucleated erythrocytes. Ac-
celerated differentiation of Raf-1–deficient cells was also
evident from quantitative analysis of other differentiation
parameters, i.e., faster maturation-associated proliferation,
cell size decrease, and hemoglobin accumulation (Fig. 2 C).
To confirm that the defect observed in the Raf-1–deficient
erythroblasts was independent from the fetal liver environ-
ment, we used erythroblasts derived from the bone marrow
of 
 
Mx-Cre
 
 
 
;c-raf-1
 
flox/flox 
 
mice treated with poly I/C to fully
convert the flox allele to a null allele (Fig. 3 A, 
 
c-raf-1
 
 
 
/
 
 
 
;
reference 9). Cells derived from poly I/C–treated 
 
Mx-
Cre
 
 
 
;
 
c-raf-1
 
flox/flox
 
 
 
animals were used as controls (
 
c-raf-1
 
f/f
 
).
After 6 d in culture in erythroid medium, both the 
 
c-raf-1
 
f/f
 
and 
 
c-raf-1
 
 
 
/
 
  
 
populations contained comparable amounts
of erythroid cells, as determined by FACS
 
® 
 
analysis (Fig. 3
B). These populations were density purified to remove
dead and differentiating cells before the induction of termi-
nal erythroid differentiation. Similar to the situation ob-
served in fetal liver–derived erythroblast, a remarkable in-
crease in nucleated (27%) and enucleated (22%) erythrocytes
was apparent in the 
 
c-raf-1
 
 
 
/
 
  
 
culture 24 h after differentia-
tion induction, whereas 
 
c-raf-1
 
f/f 
 
cultures contained only
18% nucleated and 12% enucleated erythrocytes. Thus, the
differentiation defect observed is intrinsic to the Raf-1–
deficient erythroblasts and does not depend on organ envi-
ronment.
These results suggest that delaying erythroid differentia-
tion is an essential function of Raf-1. If so, differentiating
WT cells should have a means of neutralizing this effect of
Raf-1. Indeed, immunoblot analysis showed that Raf-1 ex-
pression declines rapidly during erythroid differentiation
(Fig. 2 D). These data clearly define Raf-1 as a modulator
of erythroid maturation, which ensures homeostasis by pre-
venting the premature differentiation (and thereby the de-
pletion) of actively proliferating erythroid precursors. This
essential function of Raf-1 likely contributes to the ability
of its viral counterpart, 
 
v-raf
 
, to efficiently transform ery-
throid cells in vitro (16).
Figure 1. Fetal livers lacking Raf-1 contain lower
amounts of CFUe and Raf-1–deficient erythroblasts
show impaired expansion in culture. (A) Single cell
suspensions (105, duplicates) from fetal livers of c-raf-1 / 
or WT mice were plated in Methocult/Epo. Colonies
were scored after 2 and 3 d. Mean values of quadrupli-
cates   SD are shown. (B) Density-purified fetal liver
erythroblasts from c-raf-1 /  or WT mice were cul-
tured in erythroid medium. Cumulative cell numbers
were determined daily. (C) The morphology of c-raf-1 / 
and WT cells was analyzed on day 6. (D) Cell size pro-
files of erythroblasts were obtained by CASY measure-
ment on day 6. For B–D, one representative experi-
ment out of seven is shown. 
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By what mechanism does Raf-1 control erythroblast dif-
ferentiation? We have previously demonstrated that one
essential function of this kinase is to restrain caspase activa-
tion during apoptosis (9). Recently, caspase activation has
been found to be associated with and required for the dif-
ferentiation of human erythroblasts (6). Therefore, we
tested whether caspase activation was associated with the
differentiation of murine erythroblasts in our in vitro sys-
tem and whether Raf-1 delayed erythroid differentiation
by restraining caspase activation. Caspases are synthesized
as zymogens and converted into one large and one small
subunit by limited proteolysis. Active caspases are tetra-
mers of two large and two small subunits. We have moni-
tored limited caspase proteolysis by immunoblotting, indi-
cated by the disappearance of the zymogen (caspase-1, -3,
and -9) and/or the appearance of the small subunit
(caspase-1 and -9). Indeed, cleavage of the caspase-1, -3,
and –9 zymogens was associated with erythroid differentia-
tion (Fig. 4 A). Active caspases can, however, be efficiently
counteracted by a group of proteins called IAPs, which
bind to and inhibit the active caspase tetramer (17). To de-
termine whether the limited proteolysis of the caspase zy-
mogens corresponded to caspase activation, we tested
whether the cleavage of the death substrate Lamin B was
associated with erythroid differentiation. In this context
Lamin B is a relevant substrate because its cleavage is
needed to dissolve the nuclear membrane and is therefore
likely connected with enucleation (6).
Indeed, we observed cleavage of the 70-kD Lamin B
protein to a 40-kD diagnostic proteolytic fragment during
erythroblast differentiation of WT cells (Fig. 4 B). Treat-
ment with the cell-permeable caspase inhibitor Z-VAD-
FMK abolished the maturation-associated Lamin B cleav-
age (Fig. 4 B, top). In addition, both Z-VAD-FMK and a
second broad-range caspase inhibitor, BocD-FMK, delayed
erythroblast differentiation as measured by cell size de-
crease. After 36 h of differentiation, two distinct peaks
were well discernible in the untreated culture: large-sized
erythroblasts and small-sized mature cells. However, in in-
hibitor-treated cultures, the main peak at this time was rep-
resented by proliferating precursors (Fig. 4 C). Similarly,
the inhibitors significantly delayed and reduced the accu-
Figure 2. c-raf-1    erythroid progenitors differenti-
ate faster than their WT counterparts. (A) Morphology
of WT and c-raf-1 /  cells during differentiation.
Cytospins stained with neutral benzidine plus histologi-
cal dyes (left) were examined at each of the time points
indicated (right). (B) Cell volume profiles measured
daily show the characteristic decrease from a diameter
of 10  m to 5  m. (C) Proliferation rate during differ-
entiation (left), size decrease (middle), and hemoglobin
content (right) of WT and c-raf-1 /  cells were deter-
mined daily during terminal differentiation. (D) The
level of Raf-1 protein decreases during erythroblast
differentiation. Whole cell lysates from WT cultures
(15  g) were subjected to immunoblot analysis with an
anti–Raf-1 serum. hsp90, loading control. For A–C,
one representative experiment out of seven is shown.
Figure 3. c-raf-1 /  bone marrow–derived ery-
throid progenitors differentiate faster than their
WT counterparts. (A) Total conversion of the
floxed c-raf-1 allele to a null allele shown by PCR
analysis of bone marrow cells. (B) FACS® analysis
and (C) morphology of c-raf-1f/f and c-raf-1 /  bone
marrow–derived cells after 6 d of culture in prolif-
eration medium and (D) after 0 and 24 h of culture
in differentiation medium. The experiment was re-
peated twice with comparable results. 
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mulation of hemoglobin in the differentiating cultures (Fig.
4 D). The inhibition of caspase activation, however, did
not prevent differentiation-associated down-regulation of
Raf-1 (Fig. 4 B, middle). To assess whether, in turn, the
absence of Raf-1 had an effect on differentiation-associated
caspase activation, we determined the extent of Lamin B
cleavage in differentiating WT and 
 
c-raf-1
 
 
 
/
 
  
 
erythroblasts.
Lamin B cleavage was comparable in the terminally differ-
entiated cultures (Fig. 4 E, 48 h). However, more Lamin B
cleavage product (p40), indicative of elevated caspase activ-
ity, was present in 
 
c-raf-1
 
 
 
/
 
  
 
cultures at the start as well after
24 h of differentiation (Fig. 4 E). This was not associated
with increased apoptosis (Fig. 2 A and unpublished data)
and correlated well with the differences observed in the
amount of differentiated cells between WT and Raf-1–
deficient erythroblast culture (Fig. 2). Thus, as observed in
Raf-1–deficient macrophages (9) and fibroblasts treated by
apoptotic stimuli (unpublished data), lack of Raf-1 is asso-
ciated with an increase in caspase activation in differentiat-
ing erythroblasts.
If Raf-1 is indeed responsible for regulating erythroblast
differentiation via caspase-mediated cleavage of important
proteins, constitutive activation of Raf-1 should delay both
cleavage of caspase substrates and erythroid differentiation
itself. To confirm and extend these results, we have used
the factor-dependent differentiation-competent erythro-
blast cell line I/11 (10, 11). As in primary fetal liver–
derived erythroblasts, Raf-1 degradation accompanies the
somewhat slower differentiation of these cells (Fig. 5, A
and B). To assess whether Raf-1 overexpression would de-
lay death substrate cleavage and differentiation and whether
this required Raf-1 kinase activity, we infected I/11 cells
with retroviral constructs directing the expression of full-
length Raf-1 (WT Raf-1) and of a truncated, constitutively
active form of Raf-1 (BXB Raf-1), and selected clones ex-
pressing these proteins. Bulk populations of infected cells
and clones expressing varying amounts of the exogenous
proteins proliferated with similar kinetics in erythroid me-
dium, indicating that neither WT nor constitutively active
Raf-1 confer a selective proliferation advantage under these
conditions (unpublished data). We consistently observed
that the truncated, constitutively active (BXB) Raf-1 was
expressed at much higher levels than WT Raf-1. The rea-
sons for this are unknown. One might speculate that the
overexpression of the WT protein, containing the regula-
tory domain that binds to upstream effectors (e.g., Ras),
might compete with and block the activation of other
downstream effectors necessary for survival. This would
result in the counter selection of cells expressing high
amounts of WT Raf-1, but not of BXB. Except slightly in-
creasing proliferation during differentiation (Fig. 5 B, left),
expression of WT Raf-1 did not have a major impact on
erythroid differentiation as measured by hemoglobin accu-
mulation (right), size decrease, and cytospin analysis (C and
D). Expression of WT Raf-1 reduced Lamin B cleavage,
albeit slightly, at all time points (Fig. 5 E, right), implying
that a minimum threshold of caspase activity is necessary,
above which differentiation starts and proceed normally. In
contrast, constitutively active (BXB) Raf-1 delayed differ-
entiation, as indicated by ongoing proliferation after 72–96 h,
reduced hemoglobin accumulation (Fig. 5 B), increased
cell size (C), and persistence of partially mature and imma-
ture cells that could be switched back to proliferation con-
ditions (D and unpublished data). In parallel, BXB Raf-1
strongly delayed the cleavage of Lamin B (Fig. 5 E, right).
In proliferating cells, WT Raf-1 was expressed at high lev-
els compared with the endogenous protein but was down-
regulated in the same manner during the course of differ-
entiation. As mentioned above, BXB Raf-1 was expressed
at higher levels and because of this persisted throughout
differentiation although its amount decreased at the same
rate as that of WT Raf-1 (Fig. 5 E, left).
Figure 4. Caspase activation is necessary for the differ-
entiation of erythroid progenitors. (A) Caspase activation
accompanies the differentiation of erythroblasts. At the
indicated times after the induction of differentiation,
WT erythroblasts were lysed and the activation state of
caspase-1, -3, and -9 was analyzed by immunoblotting.
hsp90 was used as a loading control. (B) Caspase inhibi-
tors block differentiation-associated caspase activation.
WT erythroblasts were pretreated for 1 h with 150  M
broad-range caspase inhibitor Z-VAD-FMK or left un-
treated (no inhibitor) before being switched to differenti-
ation medium (with or without Z-VAD-FMK). Levels
of p70 Lamin B and its cleavage product p40 in whole
cell lysates (15  g) were detected by Western Blot analy-
sis. (C and D) Caspase inhibitors delay erythroid differ-
entiation. (C) Cell size profiles and (D) hemoglobin con-
tent of cultures treated with Z-VAD-FMK as in B or
with 150  M BocD-FMK were analyzed daily. (E)
c-raf-1 /  erythroblasts show increased Lamin B cleav-
age. WT or c-raf-1 /  erythroblasts were induced to ter-
minally differentiate. At the time points indicated, the
protein levels of p70 Lamin B and its cleavage product
p40 were determined by Western Blot analysis (15  g).
p70/p40 ratios were determined by densitometry using
the program ImageQuant. hsp90, loading control.1352 Raf-1 in Erythropoiesis
Several conclusions can be drawn from this experiment.
First, by showing that overexpression of Raf-1 restrains
caspase activation and delays erythroid differentiation, we
confirm the role of Raf-1 as a negative regulator of both
processes. Due to the differences in the expression of WT
and BXB Raf-1, however, it is not possible to deduce
whether BXB delays differentiation more efficiently than
WT Raf-1 because of its constitutive kinase activity or sim-
ply because of its higher expression. Be that as it may, the
experiment shows that a certain level of Raf-1 expression is
needed at later maturation stages for restraining differentia-
tion-induced caspase activation, whereas high level expres-
sion at the onset of differentiation has little effect on the
progress of maturation. Second, the fact that the full-length
protein expressed under the control of the retroviral pro-
moter is down-regulated with the same kinetics and effi-
ciency as endogenous Raf-1 indicates that the regulation of
Raf-1 expression occurs at the posttranscriptional level, as
also confirmed by Northern blot analysis (unpublished
data). Interestingly, we have observed posttranscriptional
Raf-1 down-regulation during pathogen-induced mac-
rophage apoptosis (9). In this case, Raf-1 was degraded by
the proteasome in a caspase-dependent manner. Thus, in
macrophages, the relationship between Raf-1 and caspase
activation was reciprocal, with the protease directing the
degradation of the kinase that restrains its activation (9). In
contrast, Raf-1 down-regulation in differentiating erythro-
blasts is either upstream of caspase activation or indepen-
dently regulated. Defining the signal directing Raf-1
down-regulation and, if possible, interfering with it will be
important in further elucidating the exact position of this
kinase in the signal transduction cascade leading to ery-
throid differentiation. An additional unsolved question is
how exactly Raf-1 controls caspase activation. It is possible
that Raf-1, or a downstream effector, directly modifies the
initiator protease(s), similar to how protein kinase B phos-
phorylates human caspase-9 and inhibits its protease activity
(18). Raf-1 might also modulate the expression or activity
of caspase inhibitors (17). In this context, in Drosophila acti-
vated D-Ras and D-Raf inhibit apoptosis by antagonizing
Hid (19, 20), whose human orthologs have been shown to
antagonize IAPs (21, 22). D-Raf, however, shares a greater
degree of homology with B-Raf than Raf-1. Furthermore,
at least in neurons, the regulation of IAP is an essential
function of B-Raf and cannot be substituted for by Raf-1
(23). The exact modalities of Raf-1 action are unclear and
will require additional study.
Raf-1 is activated by the erythroleukemia-inducing
strains of Friend spleen focus-forming virus, and its inhibi-
tion by antisense oligonucleotide partially reduces prolifer-
ation of virus-infected cells (24). In addition, oncogenic v-raf
versions cooperate with myc to transform erythroid cells
(16). p53 /  cells can be likewise transformed by v-raf, giv-
ing rise to cell lines that can be propagated continuously
and are highly tumorigenic (25). We now report a previ-
ously unrecognized function of Raf-1 as a modulator of
erythroid homeostasis, which, by restraining caspase activa-
tion, prevents the premature differentiation of erythroblasts
and safeguards the maintenance of the appropriate amount
of proliferating precursors. A delay in precursor differentia-
tion, as the one caused by mutation/overexpression of
Raf-1 (BXB Raf-1 or v-raf), should tip the balance be-
tween proliferation and terminal maturation of erythroid
cells toward precursor renewal and might represent the
main contribution of Raf to the establishment of leukemia.
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Figure 5. Overexpression of active Raf-1 delays erythroid
differentiation and differentiation-associated caspase activa-
tion in I/11 erythroblasts. (A) Raf-1 is down-regulated dur-
ing differentiation of I/11 erythroblasts. I/11 erythroblasts
were induced to differentiate. Levels of Raf-1 were detected
at the indicated time points by immunoblot analysis of 50  g
whole cell lysate. (B–D) Active Raf delays erythroid differ-
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